To assess mortality and causes of death in patients aged 60 years or older who underwent metabolic bariatric surgery compared to those receiving non-operative care for obesity, specifically focusing on the differences in outcomes between these two groups.
Key Findings:
Included 3,879 patients who underwent metabolic bariatric surgery and 19,395 matched non-operative patients, with operated patients having higher rates of diabetes and hypertension.
Interpretation:
Metabolic bariatric surgery in older patients may be associated with similar or slightly increased short-term mortality compared to non-operative treatment, highlighting the necessity for further long-term outcomes investigation.
Limitations:
Study limited to Nordic countries, which may affect generalizability.
Potential confounding factors may not have been fully accounted for, and excluding patients with a history of neoplasia may impact findings.
Conclusion:
The study suggests that metabolic bariatric surgery can be performed in older patients with careful consideration of associated risks and benefits.
